Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
06 2021
Historique:
received: 15 02 2021
accepted: 13 05 2021
revised: 11 06 2021
pubmed: 2 6 2021
medline: 21 10 2021
entrez: 1 6 2021
Statut: epublish

Résumé

In chronic Chagas disease, Trypanosoma cruzi-specific T-cell function decreases over time, and alterations in the homeostatic IL-7/IL-7R axis are evident, consistent with a process of immune exhaustion. IL-27 is an important immunoregulatory cytokine that shares T-cell signaling with IL-7 and other cytokines of the IL-12 family and might be involved in the transcriptional regulation of T-cell function. Here, we evaluated the expression and function of IL-27R in antigen-experienced T cells from subjects with chronic Chagas disease and assessed whether in vitro treatment with IL-27 and IL-7 might improve T. cruzi-specific polyfunctional T-cell responses. In vitro exposure of PBMCs to T. cruzi induced a downregulation of IL-27R in CD4+ T cells and an upregulation in CD8+ T cells in subjects without heart disease, while IL-27R expression remained unaltered in subjects with more severe clinical stages. The modulation of IL-27R was associated with functional signaling through STAT3 and STAT5 and induction of the downstream genes TBX21, EOMES and CXCL9 in response to IL-27. In vitro treatment of PBMCs with IL-27 and IL-7 improved monofunctional and polyfunctional Th1 responses, accompanied by the induction of IL-10 and Bcl-2 expression in subjects without heart disease but did not improve those in subjects with cardiomyopathy. Our findings support the process of desensitization of the IL-27/IL-27R pathway along with disease severity and that the pro-inflammatory and immunomodulatory mechanisms of IL-27 might be interconnected.

Identifiants

pubmed: 34061845
doi: 10.1371/journal.pntd.0009473
pii: PNTD-D-21-00218
pmc: PMC8195349
doi:

Substances chimiques

IL27RA protein, human 0
Interleukin-27 0
Interleukin-7 0
Receptors, Interleukin 0
STAT3 Transcription Factor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009473

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI143496
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2018 May 11;12(5):e0006480
pubmed: 29750791
J Biomed Biotechnol. 2010;2010:605483
pubmed: 20454646
Nat Rev Immunol. 2008 Apr;8(4):247-58
pubmed: 18323851
JCI Insight. 2017 Feb 9;2(3):e87499
pubmed: 28194431
JAMA. 2007 Nov 14;298(18):2171-81
pubmed: 18000201
Immunity. 2002 Jun;16(6):779-90
pubmed: 12121660
J Infect Dis. 2004 Mar 1;189(5):909-18
pubmed: 14976609
PLoS Negl Trop Dis. 2018 Dec 5;12(12):e0006998
pubmed: 30517089
J Immunol. 2015 Apr 15;194(8):3883-9
pubmed: 25769928
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15047-52
pubmed: 14657353
Mem Inst Oswaldo Cruz. 2003 Apr;98(3):407-11
pubmed: 12886425
J Immunol. 2009 Aug 15;183(4):2435-43
pubmed: 19625647
Immunobiology. 2012 Aug;217(8):768-77
pubmed: 22672991
J Immunol. 2009 Sep 15;183(6):4103-8
pubmed: 19692645
Front Immunol. 2017 Sep 26;8:1213
pubmed: 29033934
J Immunol. 2009 May 1;182(9):5748-56
pubmed: 19380822
PLoS Negl Trop Dis. 2008;2(9):e288
pubmed: 18846233
Immunity. 2001 Feb;14(2):105-10
pubmed: 11239443
Nat Immunol. 2005 Dec;6(12):1236-44
pubmed: 16273099
Front Immunol. 2017 Sep 15;8:1141
pubmed: 28966620
Cell Mol Immunol. 2008 Apr;5(2):79-89
pubmed: 18445337
PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3432
pubmed: 25569149
Front Immunol. 2019 Mar 05;10:367
pubmed: 30891038
Hum Immunol. 2014 Jan;75(1):20-8
pubmed: 24071371
Immunol Res. 2003;27(2-3):185-202
pubmed: 12857968
J Immunol. 2012 Feb 1;188(3):1178-90
pubmed: 22205023
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:208-18
pubmed: 19753476
PLoS One. 2012;7(5):e35966
pubmed: 22574131
Trends Parasitol. 2003 Oct;19(10):447-51
pubmed: 14519582
J Exp Med. 1995 Nov 1;182(5):1301-14
pubmed: 7595201
J Immunol. 2004 Apr 1;172(7):3983-8
pubmed: 15034008
Trends Parasitol. 2012 Sep;28(9):377-84
pubmed: 22832368
Infect Immun. 2010 Oct;78(10):4421-30
pubmed: 20696836
Kidney Blood Press Res. 2019;44(6):1453-1464
pubmed: 31722339
Clin Immunol. 1999 Mar;90(3):425-30
pubmed: 10075873
PLoS Negl Trop Dis. 2013 Dec 12;7(12):e2575
pubmed: 24349591
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Eur J Immunol. 2011 Jan;41(1):47-59
pubmed: 21182076
J Immunol. 2005 Jun 15;174(12):7684-91
pubmed: 15944269
J Interferon Cytokine Res. 2003 Sep;23(9):513-22
pubmed: 14565860
Clin Exp Immunol. 2018 Jul;193(1):37-46
pubmed: 29437229
J Immunol. 2010 Dec 1;185(11):6461-71
pubmed: 20974984
Immunity. 2003 Nov;19(5):657-67
pubmed: 14614853
Arch Immunol Ther Exp (Warsz). 2007 Jul-Aug;55(4):231-45
pubmed: 17659375
PLoS Negl Trop Dis. 2011 Sep;5(9):e1314
pubmed: 21909451
Cold Spring Harb Perspect Biol. 2018 Jan 2;10(1):
pubmed: 28620095
J Immunol. 2004 Sep 15;173(6):3871-7
pubmed: 15356135
Clin Infect Dis. 2009 Dec 1;49(11):1675-84
pubmed: 19877967
Eur J Immunol. 2015 Jan;45(1):192-202
pubmed: 25308526
J Immunol. 2003 May 15;170(10):4886-90
pubmed: 12734330
J Infect Dis. 2009 Jun 15;199(12):1872-82
pubmed: 19432535
Parasite Immunol. 2014 Aug;36(8):377-87
pubmed: 24611805
Annu Rev Immunol. 2015;33:417-43
pubmed: 25861977
PLoS One. 2014 Sep 09;9(9):e106004
pubmed: 25203111
PLoS Negl Trop Dis. 2013;7(1):e2038
pubmed: 23383358
J Immunol. 2015 Oct 15;195(8):3748-58
pubmed: 26385520
Nature. 2000 Oct 19;407(6806):916-20
pubmed: 11057672
Nat Immunol. 2007 Dec;8(12):1380-9
pubmed: 17994022
Rheumatology (Oxford). 2015 Jun;54(6):1103-13
pubmed: 25406356
Immunohorizons. 2019 Jan 15;3(1):13-25
pubmed: 31356173
PLoS Negl Trop Dis. 2012;6(4):e1630
pubmed: 22545173
J Immunol. 2004 Feb 15;172(4):2225-31
pubmed: 14764690
Acta Trop. 2020 Feb;202:105242
pubmed: 31669531
Immunology. 2016 Mar;147(3):338-48
pubmed: 26694585
Front Immunol. 2016 Dec 23;7:626
pubmed: 28066435
Immunity. 2014 Feb 20;40(2):289-302
pubmed: 24530057

Auteurs

María Ailén Natale (MA)

Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Todd Minning (T)

Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, United States of America.

María Cecilia Albareda (MC)

Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Melisa Daiana Castro Eiro (MD)

Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

María Gabriela Álvarez (MG)

Hospital Interzonal General de Agudos "Eva Perón", San Martín, Argentina.

Bruno Lococo (B)

Hospital Interzonal General de Agudos "Eva Perón", San Martín, Argentina.

Gonzalo Cesar (G)

Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Graciela Bertocchi (G)

Hospital Interzonal General de Agudos "Eva Perón", San Martín, Argentina.

María Josefina Elias (MJ)

Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina.

María Belén Caputo (MB)

Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina.

Rick Lee Tarleton (RL)

Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, United States of America.

Susana Adriana Laucella (SA)

Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Hospital Interzonal General de Agudos "Eva Perón", San Martín, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH